Vestibular Schwannomas covers multiple facets of vestibular schwannomas, including advancements in surgical techniques, radiological innovations, long-term patient outcomes, and implications for hearing preservation. It serves as a comprehensive guide for clinicians and researchers aiming to enhance diagnostic accuracy and therapeutic strategies in managing these complex tumors which are benign, slow-growing tumors that originate from the Schwann cells that line the vestibular nerve. They are the most prevalent neoplasms found in the cerebellopontine angle (CPA), the critical junction between the cerebellum and the brainstem.
Their incidence, clinical presentation, and impact on surrounding neurological structures make them a focal point of research and medical intervention. Understanding their etiology, diagnosis, and treatment options requires an interdisciplinary approach bridging neurology, otology, and radiology.
1. Vestibular Schwannomas - p. i 2. Cover image - p. i 3. Title page - p. i 4. Table of Contents - p. i 5. Series Page - p. i 6. Copyright - p. iv 7. Available titles - p. v 8. Foreword - p. ix 9. Preface - p. xi 10. Contributors - p. xiii 11. Chapter 1 History of vestibular schwannoma management - p. 1 12. Section I: Basic science - p. 15 13. Chapter 2 Applied anatomy in vestibular schwannoma - p. 19 14. Chapter 3 Molecular biology and disease models of vestibular schwannomas: State of the art - p. 37 15. Chapter 4 Pathology and tumor microenvironment of vestibular schwannoma - p. 47 16. Chapter 5 Genomics of vestibular schwannoma - p. 59 17. Chapter 6 Vestibular schwannomas: Key research questions and priorities - p. 69 18. Section II: Assessment - p. 79 19. Chapter 7 Clinical evaluation and investigation of patients with a sporadic vestibular schwannoma - p. 83 20. Chapter 8 Clinical evaluation and investigation of vestibular schwannoma in NF2-related schwannomatosis - p. 93 21. Chapter 9 Vestibular schwannoma imaging and differential diagnosis - p. 97 22. Chapter 10 Clinical epidemiology of sporadic vestibular schwannomas - p. 121 23. Chapter 11 Clinical epidemiology of NF2-related schwannomatosis - p. 129 24. Section III: Treatment - p. 134 25. Chapter 12 Surveillance management of vestibular schwannoma: Present and future strategies - p. 137 26. Chapter 13 Medical therapy for vestibular schwannoma - p. 145 27. Chapter 14 Translabyrinthine approach to the cerebellopontine angle - p. 149 28. Chapter 15 Retrosigmoid approach to vestibular schwannoma - p. 161 29. Chapter 16 Middle fossa approach to vestibular schwannomas - p. 167 30. Chapter 17 The retrolabyrinthine approach - p. 177 31. Chapter 18 Endoscopic vestibular schwannoma surgery - p. 185 32. Chapter 19 Vestibular schwannoma microsurgical technique - p. 197 33. Chapter 20 Outcomes following vestibular schwannoma surgery - p. 209 34. Chapter 21 Salvage resection and radiosurgery following failed primary treatment of vestibular schwannomas - p. 221 35. Chapter 22 Hearing preservation surgery for vestibular schwannoma - p. 231 36. Chapter 23 Complications of vestibular schwannoma surgery and how to minimize them - p. 239 37. Chapter 24 Anesthesia for excision of vestibular schwannoma - p. 253 38. Section IV: Stereotactic radiosurgery for vestibular schwannomas - p. 256 39. Chapter 25 Gamma Knife radiosurgery for vestibular schwannomas - p. 259 40. Chapter 26 LINAC stereotactic radiosurgery for vestibular schwannomas - p. 267 41. Chapter 27 Fractionated radiotherapy for vestibular schwannoma - p. 277 42. Chapter 28 Proton therapy for vestibular schwannomas - p. 289 43. Section V: General considerations - p. 299 44. Chapter 29 Decision-making in sporadic vestibular schwannoma - p. 303 45. Chapter 30 Decision-making in neurofibromatosis type 2 - p. 315 46. Chapter 31 Management of vestibular schwannoma in the elderly - p. 325 47. Chapter 32 Subtotal vs gross total excision of vestibular schwannomas - p. 333 48. Chapter 33 Quality of life after treatment of vestibular schwannomas - p. 341 49. Chapter 34 The role of the clinical nurse specialist in managing vestibular schwannoma - p. 347 50. Chapter 35 Vestibular schwannoma: Global perspectives - p. 359 51. Section VI: Rehabilitation - p. 365 52. Chapter 36 Secondary trigeminal neuralgia due to vestibular schwannoma - p. 369 53. Chapter 37 Hearing rehabilitation in patients with vestibular schwannomas - p. 381 54. Chapter 38 Prevention and rehabilitation of facial palsy in patients with vestibular schwannomas - p. 395 55. Chapter 39 Dizziness in vestibular schwannomas - p. 407 56. Chapter 40 Tinnitus and its management in patients with vestibular schwannoma - p. 417 57. Index - p. 433
Vestibular Schwannomas covers multiple facets of vestibular schwannomas, including advancements in surgical techniques, radiological innovations, long-term patient outcomes, and implications for hearing preservation. It serves as a comprehensive guide for clinicians and researchers aiming to enhance diagnostic accuracy and therapeutic strategies in managing these complex tumors which are benign, slow-growing tumors that originate from the Schwann cells that line the vestibular nerve. They are the most prevalent neoplasms found in the cerebellopontine angle (CPA), the critical junction between the cerebellum and the brainstem.
Their incidence, clinical presentation, and impact on surrounding neurological structures make them a focal point of research and medical intervention. Understanding their etiology, diagnosis, and treatment options requires an interdisciplinary approach bridging neurology, otology, and radiology.
1. Vestibular Schwannomas - p. i 2. Cover image - p. i 3. Title page - p. i 4. Table of Contents - p. i 5. Series Page - p. i 6. Copyright - p. iv 7. Available titles - p. v 8. Foreword - p. ix 9. Preface - p. xi 10. Contributors - p. xiii 11. Chapter 1 History of vestibular schwannoma management - p. 1 12. Section I: Basic science - p. 15 13. Chapter 2 Applied anatomy in vestibular schwannoma - p. 19 14. Chapter 3 Molecular biology and disease models of vestibular schwannomas: State of the art - p. 37 15. Chapter 4 Pathology and tumor microenvironment of vestibular schwannoma - p. 47 16. Chapter 5 Genomics of vestibular schwannoma - p. 59 17. Chapter 6 Vestibular schwannomas: Key research questions and priorities - p. 69 18. Section II: Assessment - p. 79 19. Chapter 7 Clinical evaluation and investigation of patients with a sporadic vestibular schwannoma - p. 83 20. Chapter 8 Clinical evaluation and investigation of vestibular schwannoma in NF2-related schwannomatosis - p. 93 21. Chapter 9 Vestibular schwannoma imaging and differential diagnosis - p. 97 22. Chapter 10 Clinical epidemiology of sporadic vestibular schwannomas - p. 121 23. Chapter 11 Clinical epidemiology of NF2-related schwannomatosis - p. 129 24. Section III: Treatment - p. 134 25. Chapter 12 Surveillance management of vestibular schwannoma: Present and future strategies - p. 137 26. Chapter 13 Medical therapy for vestibular schwannoma - p. 145 27. Chapter 14 Translabyrinthine approach to the cerebellopontine angle - p. 149 28. Chapter 15 Retrosigmoid approach to vestibular schwannoma - p. 161 29. Chapter 16 Middle fossa approach to vestibular schwannomas - p. 167 30. Chapter 17 The retrolabyrinthine approach - p. 177 31. Chapter 18 Endoscopic vestibular schwannoma surgery - p. 185 32. Chapter 19 Vestibular schwannoma microsurgical technique - p. 197 33. Chapter 20 Outcomes following vestibular schwannoma surgery - p. 209 34. Chapter 21 Salvage resection and radiosurgery following failed primary treatment of vestibular schwannomas - p. 221 35. Chapter 22 Hearing preservation surgery for vestibular schwannoma - p. 231 36. Chapter 23 Complications of vestibular schwannoma surgery and how to minimize them - p. 239 37. Chapter 24 Anesthesia for excision of vestibular schwannoma - p. 253 38. Section IV: Stereotactic radiosurgery for vestibular schwannomas - p. 256 39. Chapter 25 Gamma Knife radiosurgery for vestibular schwannomas - p. 259 40. Chapter 26 LINAC stereotactic radiosurgery for vestibular schwannomas - p. 267 41. Chapter 27 Fractionated radiotherapy for vestibular schwannoma - p. 277 42. Chapter 28 Proton therapy for vestibular schwannomas - p. 289 43. Section V: General considerations - p. 299 44. Chapter 29 Decision-making in sporadic vestibular schwannoma - p. 303 45. Chapter 30 Decision-making in neurofibromatosis type 2 - p. 315 46. Chapter 31 Management of vestibular schwannoma in the elderly - p. 325 47. Chapter 32 Subtotal vs gross total excision of vestibular schwannomas - p. 333 48. Chapter 33 Quality of life after treatment of vestibular schwannomas - p. 341 49. Chapter 34 The role of the clinical nurse specialist in managing vestibular schwannoma - p. 347 50. Chapter 35 Vestibular schwannoma: Global perspectives - p. 359 51. Section VI: Rehabilitation - p. 365 52. Chapter 36 Secondary trigeminal neuralgia due to vestibular schwannoma - p. 369 53. Chapter 37 Hearing rehabilitation in patients with vestibular schwannomas - p. 381 54. Chapter 38 Prevention and rehabilitation of facial palsy in patients with vestibular schwannomas - p. 395 55. Chapter 39 Dizziness in vestibular schwannomas - p. 407 56. Chapter 40 Tinnitus and its management in patients with vestibular schwannoma - p. 417 57. Index - p. 433
